| Literature DB >> 31779281 |
Bai Cham1,2,3, Shaun Scholes3, Nora E Groce3, Jennifer S Mindell3.
Abstract
BACKGROUND: Tobacco use is the leading cause of preventable death in the world, with a higher burden in low- and middle-income countries. The aim of this study was to quantify the prevalence and predictors of smoking among Gambian men using nationally representative data.Entities:
Keywords: Smoking; The Gambia; Tobacco use; WHO STEP survey
Mesh:
Year: 2019 PMID: 31779281 PMCID: PMC6926921 DOI: 10.3390/ijerph16234719
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Prevalence of smoking in men by age.
Figure 2Prevalence of smoking in men by region.
Multinomial logistic regression on factors associated with smoking in men a,b.
| Model I (Age Adjusted) | Model II (Fully Adjusted) | |||
|---|---|---|---|---|
| Ex-Smoker | Current-Smoker | Ex-Smoker | Current-Smoker | |
| Variable | a RRR(95% CI) | a RRR(95% CI) | ARRR (95% CI) | ARRR (95% CI) |
|
| ||||
| 25–34 | Reference | Reference | Reference | Reference |
| 35–44 | 1.55(0.94–2.55) | 1.03(0.77–1.38) | 2.26(1.18–4.35) * | 1.11(0.81–1.52) |
| 45–54 | 1.84(1.11–3.05) * | 0.88(0.60–1.28) | 2.12(1.15–3.93) * | 0.93(0.62–1.39) |
| 55–64 | 2.84(1.69–4.78) *** | 0.72(0.46–1.12) | 3.76(1.79–7.87) *** | 0.78(0.50–1.21) |
|
| ||||
| Mandinka | Reference | Reference | Reference | Reference |
| Wollof | 1.15(0.55–2.40) | 0.62(0.39–1.02) | 1.04(0.41–2.63) | 0.65(0.38–1.11) |
| Fula | 1.06(0.64–1.76) | 1.26(0.84–1.90) | 0.80(0.44–1.43) | 1.14(0.73–1.76) |
| Jola | 0.45(0.14–1.42) | 1.13(0.76–1.70) | 0.62(0.24–1.61) | 1.07(0.68–1.68) |
| Others | 0.57(0.25–1.29) | 0.71(0.45–1.12) | 0.63(0.36–1.12) | |
|
| ||||
| ≤ 6 Years | Reference | Reference | Reference | Reference |
| 7–12 Years | 0.78(0.47–1.30) | 0.74(0.50–1.09) | 1.00(0.50–1.90) | 0.81(0.53–1.23) |
| > 12 Years | 0.51(0.21–1.22) | 0.72(0.49–1.07) | 0.61(0.25–1.51) | 0.97(0.66–1.42) |
| Urban | Reference | Reference | Reference | Reference |
| Semi urban | 2.77(1.57–4.88) *** | 1.28(0.76–2.15) | 1.27(0.63–2.59) | 0.91(0.53–1.56) |
| Rural | 2.18(1.18–4.03) ** | 1.56(1.05–2.33) * | 0.84(0.38–1.87) | 0.92(0.62–1.37) |
|
| ||||
| ≥ 5/day | Reference | Reference | Reference | Reference |
| < 5/day | 1.11(0.55–2.26) | 1.13(0.78–1.67) | 0.99(0.47–2.04) | 1.14(0.78–1.68) |
|
| ||||
| ≥ 600METS/week | Reference | Reference | Reference | Reference |
| < 600METS/week | 0.26(0.14–0.47) *** | 0.26(0.13–0.51) *** | 0.42(0.17–1.07) | 0.77(0.42–1.43) |
|
| ||||
| Normal weight | Reference | Reference | Reference | Reference |
| Underweight | 1.71(0.97–3.02) | 1.71(1.18–2.48) *** | 2.00(1.17–3.42) ** | 1.41(0.91–2.17) |
| Overweight | 0.81(0.47–1.40) | 0.53(0.38–0.74) ** | 0.60(0.30–1.17) | 0.53(0.36–0.77) *** |
| Obese | 0.58(0.26–1.32) | 0.52(0.32–0.84) ** | 0.41(0.14–1.19) | 0.64(0.35–1.17) |
|
| ||||
| Normal | Reference | Reference | Reference | Reference |
| High | 1.44(0.92–2.27) | 0.74(0.42–1.26) | 1.96(1.26–3.04) ** | 0.73(0.42–1.28) |
|
| ||||
| No (normotensive) | Reference | Reference | Reference | Reference |
| Yes (diagnosed) | 3.99(1.94–8.20) *** | 1.02(0.49–2.11) | 2.64(1.12–6.23) *** | 1.14(0.523–2.47) |
| Yes (undiagnosed) | 1.61(0.86–3.02) | 1.06(0.76–1.48) | 1.76(0.88–3.51) | 1.10(0.44–1.50) |
Fully adjusted models: i.e., mutually adjusted for the variables shown in the table. a Data shown have been weighted for non-response and the analysis took into account the complex survey design. b Never smoking used as reference. c BMI is categorised into four groups as follows: underweight (BMI < 18.5kg/m2), normal-weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2) and obese (BMI ≥ 30kg/m2). a RRR = Relative Risk Ratio adjusted for age (except for age group as the independent variable). ARRR= Adjusted Relative Risk Ratio(fully adjusted). * p < 0.05, ** p ≤ 0.01, *** p ≤ 0.001. METS = Metabolic equivalents. d Based on the definition of the International Diabetes Federation: High waist circumference, indicating abdominal obesity defined as ≥ 90cm in men and as ≥ 80cm in women. e Hypertension defined as measured SBP ≥ 140mmHg and/or DBP ≥ 90 mmHg and/or self-reported hypertension.